Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
40
DSKYF Quote, Financials, Valuation and Earnings
Last price:
$27.05
Seasonality move
:
3.03%
Day range:
$26.35 - $29.60
52-week range:
$25.85 - $44.64
Dividend yield:
1.5%
P/E ratio:
34.06x
P/S ratio:
4.60x
P/B ratio:
4.51x
Volume:
11K
Avg. volume:
18.4K
1-year change:
3.63%
Market cap:
$51.2B
Revenue:
$11.1B
EPS (TTM):
$0.80
Analysts' Opinion
-
Consensus RatingDaiichi Sankyo has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Daiichi Sankyo has an estimated downside of -- from its current price of $27.10.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $27.10.
Fair Value
-
According to the consensus of 0 analysts, Daiichi Sankyo has -- downside to fair value with a price target of -- per share.
DSKYF vs. S&P 500
-
Over the past 5 trading days, Daiichi Sankyo has overperformed the S&P 500 by 0.28% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Daiichi Sankyo does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Daiichi Sankyo has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Daiichi Sankyo reported revenues of $2.8B.
Earnings Growth
-
Daiichi Sankyo has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Daiichi Sankyo reported earnings per share of $0.29.
Enterprise value:
46B
EV / Invested capital:
--
Price / LTM sales:
4.60x
EV / EBIT:
22.68x
EV / Revenue:
4.07x
PEG ratio (5yr expected):
0.81x
EV / Free cash flow:
13.94x
Price / Operating cash flow:
17.61x
Enterprise value / EBITDA:
18.82x
Gross Profit (TTM):
$8.5B
Return On Assets:
7.46%
Net Income Margin (TTM):
13.49%
Return On Equity:
12.79%
Return On Invested Capital:
12.99%
Operating Margin:
21.32%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | $9.1B | $9.8B | $11.3B | $2.6B | $2.8B | |
| Gross Profit | $6.1B | $7B | $8.5B | $1.9B | $2.2B | |
| Operating Income | $526M | $938.1M | $1.7B | $320.9M | $596.4M | |
| EBITDA | $1.1B | $1.6B | $2.4B | $488.5M | $826.1M | |
| Diluted EPS | $0.23 | $0.56 | $0.80 | $0.22 | $0.29 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $12.6B | $11.3B | $10.1B | $10.2B | $13.3B | |
| Total Assets | $19.7B | $18.9B | $16.8B | $17.7B | $23.1B | |
| Current Liabilities | $2.8B | $3B | $3B | $3.6B | $4.5B | |
| Total Liabilities | $7.1B | $7.1B | $6.6B | $7.1B | $11.7B | |
| Total Equity | $12.6B | $11.7B | $10.2B | $10.7B | $11.4B | |
| Total Debt | $1.7B | $1.5B | $991.7M | $765.6M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.2B | $848M | $4.2B | $265.4M | $297.2M | |
| Cash From Investing | $1.9B | -$1.9B | -$2B | $45M | -$473.9M | |
| Cash From Financing | -$768.1M | -$663.5M | -$856.3M | -$54.9M | -$45.4M | |
| Free Cash Flow | $557.1M | $349.2M | $3.3B | $125.4M | -$43M | |
DSKYF
Sector
Market Cap
$51.2B
$46.1M
Price % of 52-Week High
60.71%
46.02%
Dividend Yield
1.5%
0%
Shareholder Yield
1.3%
-0.6%
1-Year Price Total Return
3.63%
-30.52%
Beta (5-Year)
0.348
0.772
Dividend yield:
1.5%
Annualized payout:
$0.33
Payout ratio:
16.71%
Growth streak:
1 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$27.23
200-day SMA
Sell
Level
$33.86
Bollinger Bands (100)
Sell
Level
29.34 - 38.08
Chaikin Money Flow
Sell
Level
-128.7K
20-day SMA
Sell
Level
$29.14
Relative Strength Index (RSI14)
Sell
Level
44.19
ADX Line
Buy
Level
15.23
Williams %R
Buy
Level
-83.2215
50-day SMA
Sell
Level
$30.44
MACD (12, 26)
Sell
Level
-1.05
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
339.2K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.9773)
Buy
CA Score
(Annual)
Level (0.2354)
Buy
Beneish M-Score
(Annual)
Level (-2.9206)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.8025)
Buy
Piotroski F Score
(Annual)
Level (9)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2021, approximately half of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), and HER3-DXd (HER3). Enhertu entered the clinic in 2015 and received its first U.S Food and Drug Administration approval in December 2019 for third-line late-stage HER2-positive breast cancer and its high efficacy is changing the treatment landscape for HER-expressing breast cancers. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.
Stock Forecast FAQ
In the current month, DSKYF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DSKYF average analyst price target in the past 3 months is --.
-
Where Will Daiichi Sankyo Stock Be In 1 Year?
According to analysts, the consensus estimate is that Daiichi Sankyo share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Daiichi Sankyo?
Analysts are divided on their view about Daiichi Sankyo share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Daiichi Sankyo is a Sell and believe this share price will rise from its current level to --.
-
What Is Daiichi Sankyo's Price Target?
The price target for Daiichi Sankyo over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DSKYF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Daiichi Sankyo is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of DSKYF?
You can purchase shares of Daiichi Sankyo via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Daiichi Sankyo shares.
-
What Is The Daiichi Sankyo Share Price Today?
Daiichi Sankyo was last trading at $27.05 per share. This represents the most recent stock quote for Daiichi Sankyo. Yesterday, Daiichi Sankyo closed at $27.10 per share.
-
How To Buy Daiichi Sankyo Stock Online?
In order to purchase Daiichi Sankyo stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
